Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656577 · ClinicalTrials.gov registry record · Early Phase 1
Pexacerfont for Stress-induced Food Craving
A Early Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT01656577 is a Early Phase 1 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 31 participants.
The verdict
NCT01656577, a Early Phase 1 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
Background: \- Stress can cause people to give in to temptations to eat less healthily. People who are on weight loss diets often have problems sticking to their diets when they are stressed. Some tests have shown that the drug pexacerfont can help reduce stress-related seeking of high-calorie foods. However, it has not been tested on reducing food craving. Researchers want to test pexacerfont on people who are on diets to see if it can reduce stress-related food cravings. Objectives: \- To see if pexacerfont can help reduce stress-induced food cravings. Eligibility: \- Individuals between 21 and 65 years of age who are on a diet to control their weight. Design: * Participants will be screened with a physical exam and medical history. This study requires seven visits over about 35 days. * Participants will take either pexacerfont or placebo pills during the study. They will have three pills every morning. They will record video of themselves taking the pills every day. * Every evening, participants will fill out a questionnaire. It will ask questions about feelings and behaviors related to eating and food craving. * Participants will have regular study visits while taking the pills. The visits will involve questions about stressful situations and food cravings. One visit will involve a mildly stressful math test, followed by tasting of different foods. This test will look at whether pexacerfont can affect food preferences. Participants will provide blood and saliva samples as directed at these study visits. * Participants will have follow-up phone calls 1, 3, and 6 months after the end of the study.
Interventions
- DRUG Pexacerfont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01656577
The ClinicalTrials.gov registry entry for NCT01656577 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pexacerfont is the first listed.
NCT01656577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01656577 about?
NCT01656577 is a clinical study titled "Pexacerfont for Stress-induced Food Craving". Background: \- Stress can cause people to give in to temptations to eat less healthily. People who are on weight loss diets often have problems sticking to their diets when they are stressed. Some tests have shown that the drug pexacerfont can help reduce stress-related seeking of high-calorie food...
What is the current status of trial NCT01656577?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2012-06. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01656577?
The interventions under investigation include: Pexacerfont (DRUG).
Who is sponsoring clinical trial NCT01656577?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.